Natural and chemical compounds as protective agents against cardiac lipotoxicity
Cardiac lipotoxicity results from the deleterious effects of excess lipid deposition in cardiomyocytes. Lipotoxic cardiomyopathy involves cardiac lipid overload leading to changes in myocardial structure and function. Cardiac dysfunction has been associated with cardiac lipotoxicity through abnormal...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dedfaf21cd7348379ab015c891db3a3e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:dedfaf21cd7348379ab015c891db3a3e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:dedfaf21cd7348379ab015c891db3a3e2021-11-14T04:30:33ZNatural and chemical compounds as protective agents against cardiac lipotoxicity0753-332210.1016/j.biopha.2021.112413https://doaj.org/article/dedfaf21cd7348379ab015c891db3a3e2022-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0753332221011999https://doaj.org/toc/0753-3322Cardiac lipotoxicity results from the deleterious effects of excess lipid deposition in cardiomyocytes. Lipotoxic cardiomyopathy involves cardiac lipid overload leading to changes in myocardial structure and function. Cardiac dysfunction has been associated with cardiac lipotoxicity through abnormal lipid metabolism. Lipid accumulation, especially saturated free fatty acids (SFFAs), in cardiac cells can cause cardiomyocyte distress and subsequent myocardial contractile dysfunction. Reducing the excess FAs supply or promoting FA storage is beneficial for cardiac function, especially under a lipotoxic condition.The protective effects of several compounds against lipotoxicity progression in the heart have been investigated. A variety of mechanisms has been suggested to prevent or treat cardiac lipotoxicity, including improvement of calcium homeostasis, lipid metabolism, and mitochondrial dysfunction. Known targets and signaling pathways involving a select group of chemicals that interfere with cardiac lipotoxicity pathogenesis are reviewed.Fatemeh YarmohammadiA. Wallace HayesGholamreza KarimiElsevierarticleβ-oxidationCardiomyopathyLipotoxicityMetabolismMitochondriaTherapeutics. PharmacologyRM1-950ENBiomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112413- (2022) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
β-oxidation Cardiomyopathy Lipotoxicity Metabolism Mitochondria Therapeutics. Pharmacology RM1-950 |
spellingShingle |
β-oxidation Cardiomyopathy Lipotoxicity Metabolism Mitochondria Therapeutics. Pharmacology RM1-950 Fatemeh Yarmohammadi A. Wallace Hayes Gholamreza Karimi Natural and chemical compounds as protective agents against cardiac lipotoxicity |
description |
Cardiac lipotoxicity results from the deleterious effects of excess lipid deposition in cardiomyocytes. Lipotoxic cardiomyopathy involves cardiac lipid overload leading to changes in myocardial structure and function. Cardiac dysfunction has been associated with cardiac lipotoxicity through abnormal lipid metabolism. Lipid accumulation, especially saturated free fatty acids (SFFAs), in cardiac cells can cause cardiomyocyte distress and subsequent myocardial contractile dysfunction. Reducing the excess FAs supply or promoting FA storage is beneficial for cardiac function, especially under a lipotoxic condition.The protective effects of several compounds against lipotoxicity progression in the heart have been investigated. A variety of mechanisms has been suggested to prevent or treat cardiac lipotoxicity, including improvement of calcium homeostasis, lipid metabolism, and mitochondrial dysfunction. Known targets and signaling pathways involving a select group of chemicals that interfere with cardiac lipotoxicity pathogenesis are reviewed. |
format |
article |
author |
Fatemeh Yarmohammadi A. Wallace Hayes Gholamreza Karimi |
author_facet |
Fatemeh Yarmohammadi A. Wallace Hayes Gholamreza Karimi |
author_sort |
Fatemeh Yarmohammadi |
title |
Natural and chemical compounds as protective agents against cardiac lipotoxicity |
title_short |
Natural and chemical compounds as protective agents against cardiac lipotoxicity |
title_full |
Natural and chemical compounds as protective agents against cardiac lipotoxicity |
title_fullStr |
Natural and chemical compounds as protective agents against cardiac lipotoxicity |
title_full_unstemmed |
Natural and chemical compounds as protective agents against cardiac lipotoxicity |
title_sort |
natural and chemical compounds as protective agents against cardiac lipotoxicity |
publisher |
Elsevier |
publishDate |
2022 |
url |
https://doaj.org/article/dedfaf21cd7348379ab015c891db3a3e |
work_keys_str_mv |
AT fatemehyarmohammadi naturalandchemicalcompoundsasprotectiveagentsagainstcardiaclipotoxicity AT awallacehayes naturalandchemicalcompoundsasprotectiveagentsagainstcardiaclipotoxicity AT gholamrezakarimi naturalandchemicalcompoundsasprotectiveagentsagainstcardiaclipotoxicity |
_version_ |
1718429988628201472 |